PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Water extracts showed anti-urolithiatic potential by inhibiting calcium oxalate crystal nucleation and aggregation [PMID:36260052].
Alcoholic stem extract significantly reduced fasting blood glucose levels in STZ-nicotinamide induced diabetic rats [PMID:15707777, 16136216].
Stem extracts exhibited dose-related hypotensive action in anesthetized dogs, rats, and guinea pigs [PMID:2255206, 17229538].
Extracts showed antibacterial activity, specifically against Neisseria gonorrhoeae with an MIC of 47.39 microg/ml, attributed to berberine [PMID:16112497, 19429310].
Extracts demonstrated antiproliferative and cytotoxic activity against human HN31 (pharynx), Hep-2, and colorectal cancer cells [PMID:12081142, 26074999, 23136612].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35890469 (2022) — The Cholesterol-Modulating Effect of the New Herbal Medicinal Recipe from Yellow Vine (Coscinium fenestratum (Goetgh.)), Ginger (Zingiber officinale Roscoe.), and Safflower (Carthamus tinctorius L.) on Suppressing PCSK9 Expression to Upregulate LDLR Expression in HepG2 Cells. · Plants (Basel, Switzerland)
- 2.PMID: 16112497 (2005) — Antibacterial effects of Coscinium fenestratum. · Fitoterapia
- 3.PMID: 37293467 (2023) — Berberine isolation from Coscinium fenestratum: optical, electrochemical, and computational studies. · RSC advances
- 4.PMID: 36260052 (2023) — Evaluation of Coscinium fenestratum (Goetgh.) Colebr. stem extracts for urolithiasis and quantification of bioactive alkaloids to validate the traditional claims. · Natural product research
- 5.PMID: 22556968